Format

Send to

Choose Destination
Genome Med. 2012 Jan 27;4(1):3. doi: 10.1186/gm302.

Recycling side-effects into clinical markers for drug repositioning.

Author information

1
Joint IRB-BSC Program in Computational Biology, Institute for Research in Biomedicine (IRB) Barcelona, c/Baldiri Reixac 10-12, 08028 Barcelona, Spain. patrick.aloy@irbbarcelona.org.

Abstract

Side-effects are the unintended consequence of therapeutic treatments, but they can also be seen as valuable read-outs of drug effects in humans; these effects are difficult to infer or predict from pre-clinical models. Indeed, some studies suggest that drugs with similar side-effect profiles may also share therapeutic properties through related mechanisms of action. A recent publication exploits this concept to systematically investigate new indications for already marketed drugs, and presents a strategy to get the most out of the tiny portion of chemicals that have proved to be effective and safe.

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center